BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
BOSTON SCIENTIFIC CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $904,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $355,000,000.00Accounts payable, accrued expenses and other liabilities → Operating adjustments reconciliation: $234,000,000.00Stock-based compensation expense → Operating adjustments reconciliation: $87,000,000.00Other, net → Operating adjustments reconciliation: $36,000,000.00Other assets → Operating adjustments reconciliation: $19,000,000.00Deferred and prepaid income taxes → Operating adjustments reconciliation: $17,000,000.00Net loss (gain) on investments and notes receivable → Operating adjustments reconciliation: $12,000,000.00Inventory step-up amortization → Operating adjustments reconciliation: $4,000,000.00Remaining operating cash flows, net (calculated) → Operating adjustments reconciliation: $1,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $570,000,000.00Operating adjustments reconciliation → Inventories: $133,000,000.00Operating adjustments reconciliation → Trade accounts receivable: $46,000,000.00Operating adjustments reconciliation → Contingent consideration net expense (benefit): $16,000,000.00investing reconciliation → Remaining investing cash flows, net (calculated): $1,561,000,000.00investing reconciliation → Purchases of property, plant and equipment and internal use software: $195,000,000.00investing reconciliation → Payments for acquisitions of businesses, net of cash acquired: $195,000,000.00investing reconciliation → Other, net: $5,000,000.00Net cash used in financing activities → financing reconciliation: $410,000,000.00Net increase (decrease) in commercial paper → financing reconciliation: $1,675,000,000.00Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans → financing reconciliation: $5,000,000.00Other, net → financing reconciliation: $5,000,000.00financing reconciliation → Remaining financing cash flows, net (calculated): $2,079,000,000.00financing reconciliation → Payments on short-term borrowings: $13,000,000.00financing reconciliation → Cash used to net share settle employee equity awards: $3,000,000.00Net cash used in investing activities → investing reconciliation: $1,956,000,000.00Exchange-rate effect → Cash sources and uses: $1,000,000.00Difference in the filed cash totals (calculated) → Cash sources and uses: $1,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,643,000,000.00Net cash from operating activities → Cash sources and uses: $1,474,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $753,000,000.00Cash sources and uses → Net cash used in investing activities: $1,956,000,000.00Cash sources and uses → Net cash used in financing activities: $410,000,000.00Net income (loss): $904,000,000.00Net income (loss)+$904.00 MDepreciation and amortization: $355,000,000.00Depreciation & amortization+$355.00 MDeferred and prepaid income taxes: $17,000,000.00Deferred & prepaid income taxes+$17.00 MStock-based compensation expense: $87,000,000.00Stock-based compensation+$87.00 MNet loss (gain) on investments and notes receivable: $12,000,000.00Investment gain & loss+$12.00 MContingent consideration net expense (benefit): -$16,000,000.00Contingent consideration change−$16.00 MInventory step-up amortization: $4,000,000.00Inventory step-up amortization+$4.00 MOther, net: $36,000,000.00Other operating, net+$36.00 MTrade accounts receivable: -$46,000,000.00Accounts receivable−$46.00 MInventories: -$133,000,000.00Inventories−$133.00 MOther assets: $19,000,000.00Other operating assets+$19.00 MAccounts payable, accrued expenses and other liabilities: $234,000,000.00Payables & accrued liabilities+$234.00 MRemaining operating cash flows, net (calculated): $1,000,000.00Remaining operating (calculated)+$1.00 MNet cash from operating activities: $1,474,000,000.00Operating cash+$1.47 BOperating adjustments reconciliation: $765,000,000.00Payments for finance leases: -$0.00Payments on short-term borrowings: -$13,000,000.00Short-term debt repaid−$13.00 MNet increase (decrease) in commercial paper: $1,675,000,000.00Commercial paper, net+$1.68 BProceeds from long-term borrowings, net of debt issuance costs: $0.00Cash used to net share settle employee equity awards: -$3,000,000.00Equity award net settlement−$3.00 MProceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans: $5,000,000.00Stock plan proceeds+$5.00 MOther, net: $5,000,000.00Other financing, net+$5.00 MRemaining financing cash flows, net (calculated): -$2,079,000,000.00Remaining financing (calculated)−$2.08 BNet cash used in financing activities: -$410,000,000.00. Cash required to fund net payments.Financing cash−$410.00 Mfinancing reconciliation: $2,095,000,000.00Purchases of property, plant and equipment and internal use software: -$195,000,000.00PP&E purchases−$195.00 MPayments for acquisitions of businesses, net of cash acquired: -$195,000,000.00Acquisitions, net of cash−$195.00 MOther, net: -$5,000,000.00Other investing, net−$5.00 MRemaining investing cash flows, net (calculated): -$1,561,000,000.00Remaining investing (calculated)−$1.56 BNet cash used in investing activities: -$1,956,000,000.00. Cash required to fund net payments.Investing cash−$1.96 Binvesting reconciliation: $1,956,000,000.00Cash sources and uses: $3,119,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,643,000,000.00Beginning cash$1.64 BEnding cash: Cash, cash equivalents, and restricted cash: $753,000,000.00Ending cash$753.00 MExchange-rate effect: $1,000,000.00FX effect+$1.00 MDifference in the filed cash totals (calculated): $1,000,000.00Filer's cash difference(calculated)+$1.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$1.28 BOperating cash − cash spent on PP&ECash flow / Net income1.63×Operating cash flow ÷ net incomeNet cash change−$890.00 MEnding cash − beginning cash
Chart details

BOSTON SCIENTIFIC CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
1,643,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
1,474,000,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. The filing's tagged operating lines do not add up to the operating total; this is the difference. It may combine inflows and outflows.
Net income (loss)
904,000,000 US dollars
Depreciation and amortization
355,000,000 US dollars
Deferred and prepaid income taxes
17,000,000 US dollars
Stock-based compensation expense
87,000,000 US dollars
Net loss (gain) on investments and notes receivable
12,000,000 US dollars
Contingent consideration net expense (benefit)
negative 16,000,000 US dollars
Inventory step-up amortization
4,000,000 US dollars
Other, net
36,000,000 US dollars
Trade accounts receivable
negative 46,000,000 US dollars
Inventories
negative 133,000,000 US dollars
Other assets
19,000,000 US dollars
Accounts payable, accrued expenses and other liabilities
234,000,000 US dollars
Remaining operating cash flows, net (calculated)
1,000,000 US dollars
Investing activities
negative 1,956,000,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the investing total. The filing's tagged investing lines do not add up to the investing total; this is the difference. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from (payments for) investments and acquisitions of certain technologies), so Payments for investments and acquisitions of certain technologies and Proceeds from sale of investments and dispositions of certain technologies cannot be separated for this quarter. It may combine inflows and outflows.
Purchases of property, plant and equipment and internal use software
negative 195,000,000 US dollars
Payments for acquisitions of businesses, net of cash acquired
negative 195,000,000 US dollars
Other, net
negative 5,000,000 US dollars
Remaining investing cash flows, net (calculated)
negative 1,561,000,000 US dollars
Financing activities
negative 410,000,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the financing total. The filing's tagged financing lines do not add up to the financing total; this is the difference. It may combine inflows and outflows.
Payments for finance leases
0 US dollars
Payments on short-term borrowings
negative 13,000,000 US dollars
Net increase (decrease) in commercial paper
1,675,000,000 US dollars
Proceeds from long-term borrowings, net of debt issuance costs
0 US dollars
Cash used to net share settle employee equity awards
negative 3,000,000 US dollars
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans
5,000,000 US dollars
Other, net
5,000,000 US dollars
Remaining financing cash flows, net (calculated)
negative 2,079,000,000 US dollars
Operating adjustment reconciliation
765,000,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing displayed reconciliation
2,095,000,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
investing displayed reconciliation
1,956,000,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
Exchange-rate effect
1,000,000 US dollars
Difference in the filed cash totals (calculated)
1,000,000 US dollars. Into cash; drawn as the small gray flow above beginning cash.
Ending cash on Jun 30, 2026
753,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,119,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 890,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.63×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
1,474,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
195,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
1,279,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $570.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Cash-flow net income is $904.00 M, derived by subtracting the earlier cumulative period; the income statement reports $905.00 M for the same period. The $1.00 M difference is rounding: the filing reports each amount rounded to the nearest million dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
  • The filer's reported cash figures differ by $1.00 M: its operating, investing and financing totals and exchange-rate effect do not add up to its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,474,000,000 US dollars minus 195,000,000 US dollars equals 1,279,000,000 US dollars.
  • Cash-flow net income is $904.00 M, derived by subtracting the earlier cumulative period; the income statement reports $905.00 M for the same period. The $1.00 M difference is rounding: the filing reports each amount rounded to the nearest million dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
  • The filer's reported cash figures differ by $1.00 M: its operating, investing and financing totals and exchange-rate effect do not add up to its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!